Patents by Inventor Dana GOLDENBERG

Dana GOLDENBERG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPTIMIZED POLYPEPTIDE FOR A SUBUNIT VACCINE AGAINST AVIAN REOVIRUS
    Publication number: 20240050556
    Abstract: An isolated polypeptide comprising an amino acid sequence corresponding to the amino acid residues forming a full or partial ?-helical domain, the hinge domain, the ?-triple spiral domain and a full or partial globular head domain of an avian reovirus sigma C protein, and lacking the amino acid sequence that is N-terminal to said ?-helical domain is provided. Furthermore, a vaccine comprising, or a viral vector expressing, at least one of the isolated polypeptides of the present invention is provided.
    Type: Application
    Filed: July 24, 2023
    Publication date: February 15, 2024
    Applicant: GAVISH-GALILEE BIO APPLICATIONS, LTD
    Inventors: Jacob PITCOVSKI, Dana Goldenberg
  • Optimized polypeptide for a subunit vaccine against avian reovirus
    Patent number: 11541111
    Abstract: An isolated polypeptide comprising an amino acid sequence corresponding to the amino acid residues forming a full or partial ?-helical domain, the hinge domain, the ?-triple spiral domain and a full or partial globular head domain of an avian reovirus sigma C protein, and lacking the amino acid sequence that is N-terminal to said ?-helical domain is provided. Furthermore, a vaccine comprising, or a viral vector expressing, at least one of the isolated polypeptides of the present invention is provided.
    Type: Grant
    Filed: January 5, 2017
    Date of Patent: January 3, 2023
    Assignee: GAVISH-GALILEE BIO APPLICATIONS, LTD.
    Inventors: Jacob Pitcovski, Dana Goldenberg
  • OPTIMIZED POLYPEPTIDE FOR A SUBUNIT VACCINE AGAINST AVIAN REOVIRUS
    Publication number: 20190290752
    Abstract: An isolated polypeptide comprising an amino acid sequence corresponding to the amino acid residues forming a full or partial ?-helical domain, the hinge domain, the ?-triple spiral domain and a full or partial globular head domain of an avian reovirus sigma C protein, and lacking the amino acid sequence that is N-terminal to said ?-helical domain is provided. Furthermore, a vaccine comprising, or a viral vector expressing, at least one of the isolated polypeptides of the present invention is provided.
    Type: Application
    Filed: January 5, 2017
    Publication date: September 26, 2019
    Applicant: GAVISH-GALILEE BIO APPLICATIONS, LTD
    Inventors: Jacob PITCOVSKI, Dana GOLDENBERG